Seeing Is Believing
Currently out of the existing stock ratings of Morten Herholdt, 6 are a BUY (54.55%), 3 are a HOLD (27.27%), 2 are a SELL (18.18%).
Analyst Morten Herholdt, currently employed at HSBC, carries an average stock price target met ratio of 29.17% that have a potential upside of 6.64% achieved within 190 days.
Morten Herholdt’s has documented 21 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GILD, Gilead Sciences at 06-Jul-2026.
Analyst best performing recommendations are on GILD (GILEAD SCIENCES).
The best stock recommendation documented was for GILD (GILEAD SCIENCES) at 9/6/2023. The price target of $71 was fulfilled within 8 days with a profit of $3.29 (4.86%) receiving and performance score of 6.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Jul-2025
$235
$32.81 (16.23%)
$189
18 days ago
(13-Jul-2026)
5/8 (62.5%)
$25.97 (12.42%)
164
Hold Since 13-Feb-2025
$222
$19.81 (9.80%)
$224
23 days ago
(08-Jul-2026)
38/66 (57.58%)
$21.64 (10.80%)
321
Buy Since 04-Mar-2022
$242
$39.81 (19.69%)
$227
24 days ago
(07-Jul-2026)
48/83 (57.83%)
$36.3 (17.65%)
148
Buy Since 29-Jun-2026
$256
$53.81 (26.61%)
$255
1 months 2 days ago
(29-Jun-2026)
7/37 (18.92%)
$39.37 (18.17%)
256
Buy Since 28-Sep-2022
$221
$4.97 (2.30%)
$177
1 months 16 days ago
(15-Jun-2026)
24/40 (60%)
$22.36 (11.26%)
155
Which stock is Morten Herholdt is most bullish on?
Which stock is Morten Herholdt is most reserved on?
What Year was the first public recommendation made by Morten Herholdt?